Drug intelligence / Profile preview

A to Zed

Development stage: Unknown
Lead developer: Greenlife Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

A to Zed is an oral multivitamin and mineral supplement developed by Greenlife Pharmaceuticals, a Nigerian generic pharmaceutical company. The formulation contains a blend of essential vitamins, iron, and various minerals. It is designed to provide comprehensive nutritional support and is specifically indicated for use during illness, pregnancy, and lactation to address or prevent micronutrient deficiencies. As a multivitamin product, it supports various physiological functions by providing necessary cofactors and elements for metabolism and health maintenance.

Brand names: A TO ZED
Other names: A TO ZED CAPSULE

Beyond the preview

Go deeper on A to Zed.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on A to Zed.

Explore the full profile